ARMO BioSciences' IPO

ARMO BioSciences raised a round of funding on January 26, 2018. Investors include Public.

ARMO BioSciences is focused on developing immunotherapies for the treatment of cancer, fibrosis, hypercholesterolemia/atherosclerosis and inflammatory diseases. ARMO believes that by harnessing the bo…

Articles about ARMO BioSciences' IPO: